Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-01
2008-07-01
Kim, Jennifer (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S651000, C514S212010, C514S317000, C514S428000
Reexamination Certificate
active
09930105
ABSTRACT:
The present invention provides methods for the modulation of vascular tone in a patient having compromised vascular tissue, which methods comprise the administration of a chloride channel blocking agent or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5077601 (1991-12-01), Hatada et al.
patent: 5224538 (1993-07-01), Jacoby
patent: 5470883 (1995-11-01), Stromberg
patent: 5472985 (1995-12-01), Grainger et al.
patent: 5658936 (1997-08-01), Kifor et al.
patent: 5691355 (1997-11-01), Bryant et al.
patent: 5760066 (1998-06-01), Tang
patent: 5770609 (1998-06-01), Grainger et al.
patent: 5795898 (1998-08-01), Brown et al.
patent: 5811447 (1998-09-01), Kunz et al.
patent: 5912805 (1999-06-01), Freuler et al.
patent: 5940269 (1999-08-01), Ko et al.
patent: 5957194 (1999-09-01), Azar
patent: 6015008 (2000-01-01), Kogure et al.
patent: 6054198 (2000-04-01), Bunyan et al.
patent: 6197789 (2001-03-01), Grainger et al.
patent: 6266560 (2001-07-01), Zhang et al.
patent: WO-96/40098 (1996-12-01), None
Delaney et al. Increased libido: a complication of tamoxifen therapy of male breast cancer. The breast, 1996 5, pp. 53-54.
Drug Facts and Comparisons, 1997 p. 3162.
Andreas, S.,et al., “Characterization of cell volume-sensitive chloride currents in freshly prepared and cultured pancreatic acinar cells from early postnatal rats”,J. of Physiology, 513 (2), (Dec. 1, 1998), 453-465.
Borsani, G.,et al., “Characterization of a Human and Murine Gene (CLCN3) Sharing Similarities to Voltage-Gated Chloride Channels and to a Yeast Integral Membrane Protein”,Genomics, 27, (1995), pp. 131-141.
Dick, G.M., et al., “Functional and molecular identification of a novel chloride conductance in canine colonic smooth muscle”,Am. J. of Physiology, 275 (4), Part 1, (Oct. 1998), C940-C950.
Duan, D., et al., “Molecular identification of a volume-regulated chloride channel”,Nature, 390, (Nov. 1997), pp. 417-421.
Kawasaki, M..,et al. ,“Stable and Functional Expression of the ClC-3 Chloride Channel in Somatic Cell Lines”,Neuron, 14, (Jun. 1995), pp. 1285-1291.
Lamb, F.S., et al., “Chloride ion currents contribute functionally to norepinephrine-induced vascular contraction”,Am. J. Physiol., 275, (1998), pp. H151-H160.
Lamb, F.S., et al., “The endothelium modulates the contribution of chloride currents to norepinephrine-induced vascular contraction”,Am. J. Physiol., 275, (1998), H161-H168.
Liu, B-X., et al., “Tamoxifen Normalizes the Increase in Vascular Sensitivity Associated with Endothelial Disruption”,FASEB Journal, 13 (4), Part 1, Abstract, (Mar. 12, 1999), p. A49.
Qiu, X.C., et al., “The cardiovascular reactions mediated by TPA and tamoxifen in spinal cord of conscious rats”,Yaoxue Xuebao, 30 (7), (1995), 481-485.
Yamazaki, J., et al., “Functional and Molecular expression of volume-regulated chloride channels in canine vascular smooth muscle cells”,J. of Physiology, 507 (3), (Mar. 15, 1998), 729-736.
Ralph, D. J., et al., “The Treatment of Peyronie's Disease with Tamoxifen”,British Journal of Urology, 70, Abstract, Database EMBASE on ACS. Accession No. 93001761,(1992),648-651.
Lamb Fred S.
Schutte Brian C.
Yang Baoli
Kim Jennifer
University of Iowa Research Foundation
Viksnins Harris & Padys PLLP
LandOfFree
Use of ClC3 chloride channel blockers to modulate vascular tone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ClC3 chloride channel blockers to modulate vascular tone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ClC3 chloride channel blockers to modulate vascular tone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3940866